Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bendamustine + Rituximab in Indolent Non-follicular NHL
NCT01929265Phase 2Completed
- Sponsor
- Fondazione Italiana Linfomi
- Start
- Jan 2011
- Primary completion
- Mar 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Mecbentu in non-Hodgkin lymphoma (NHL), sponsored by Fondazione Italiana Linfomi. Started Jan 2011; status: completed.
02
Drugs
Mecbentu
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT01929265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01929265.